首页> 美国政府科技报告 >Invalid Prescriber Identifiers on Medicare Part D Drug Claims
【24h】

Invalid Prescriber Identifiers on Medicare Part D Drug Claims

机译:医疗保险D部分药物索赔的无效处方者标识符

获取原文

摘要

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 established Part D to provide an optional prescription drug benefit for all Medicare beneficiaries. The Centers for Medicare & Medicaid Services (CMS) contracts with private companies, called plan sponsors, to administer the benefit through Part D drug plans. Part D plans must submit an electronic record, called a PDE record, to CMS for each covered prescription filled for their enrollees. CMS requires that most PDE records contain an identifier for the drug's prescriber. Acceptable prescriber identifiers include National Provider Identifiers (NPI), Drug Enforcement Administration (DEA) registration numbers, Unique Physician Identification Numbers (UPIN), and State license numbers. To determine the extent to which invalid prescriber identifiers were used on Part D claims, we compared prescriber identifiers that appeared on PDE records in 2007 to identifiers enumerated in NPI, DEA number, and UPIN registries.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号